BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3901888)

  • 1. The R-proteins.
    Christensen KK; Christensen P
    Antibiot Chemother (1971); 1985; 35():114-8. PubMed ID: 3901888
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial carbohydrates in neonatal sepsis: targets for immunotherapy.
    Raff HV
    Springer Semin Immunopathol; 1993; 15(2-3):173-81. PubMed ID: 8256196
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
    Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
    Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B streptococci: determinants of invasive neonatal infection.
    Boyer KM
    Mead Johnson Symp Perinat Dev Med; 1982; (21):47-51. PubMed ID: 6765459
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to GBS.
    Christensen KK; Christensen P; Seger RA
    Antibiot Chemother (1971); 1985; 35():247-53. PubMed ID: 3901901
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG subclasses and neonatal infections with group B streptococci.
    Christensen KK; Christensen P
    Monogr Allergy; 1988; 23():138-47. PubMed ID: 2455218
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous gamma-globulin in the treatment of neonatal sepsis with special reference to group B streptococci and pharmacokinetics.
    Christensen KK; Christensen P
    Pediatr Infect Dis; 1986; 5(3 Suppl):S189-92. PubMed ID: 3520505
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell structure and antigenic composition of GBS.
    Kasper DL; Baker CJ; Jennings HJ
    Antibiot Chemother (1971); 1985; 35():90-100. PubMed ID: 3901913
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
    Bevanger L; Naess AI
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunoreactive extracellular proteins of Streptococcus agalactiae in bovine mastitis.
    Trigo G; Ferreira P; Ribeiro N; Dinis M; Andrade EB; Melo-Cristino J; Ramirez M; Tavares D
    Can J Microbiol; 2008 Nov; 54(11):899-905. PubMed ID: 18997846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group-B streptococcus--profile of an organism.
    Ross PW
    J Med Microbiol; 1984 Oct; 18(2):139-66. PubMed ID: 6387125
    [No Abstract]   [Full Text] [Related]  

  • 12. Group B streptococcal infection in humans.
    Wilkinson HW
    Annu Rev Microbiol; 1978; 32():41-57. PubMed ID: 360972
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular and humoral aspects of host defense mechanisms against GBS.
    Gotoff SP; Boyer KM
    Antibiot Chemother (1971); 1985; 35():142-56. PubMed ID: 3901891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphological and immunological characteristics of organic lesions in experimental infection with the L form of Streptococcus group B].
    Vartazarian ND; Gorina LG; Ambarzhanian RS; Goncharova SA; Khostikian NG
    Vestn Akad Med Nauk SSSR; 1986; (7):22-7. PubMed ID: 3529689
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis.
    Sigge A; Schmid M; Mauerer S; Spellerberg B
    J Clin Microbiol; 2008 Feb; 46(2):807-9. PubMed ID: 18077645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indicators of the persistence of L-forms of group B Streptococcus in experimental infection of animals].
    Gorina LG; Goncharova SA; Vartazarian ND; Zheverzheeva IV
    Vestn Akad Med Nauk SSSR; 1985; (10):58-61. PubMed ID: 3909686
    [No Abstract]   [Full Text] [Related]  

  • 17. The potential impact of group B streptococcal antibodies in breast milk.
    Weisman LE; Dobson FM
    Adv Exp Med Biol; 1991; 310():345-51. PubMed ID: 1809009
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies raised in animals against the Streptococcus agalactiae proteins c alpha and R4 and normal human serum antibodies target distinct epitopes.
    Moyo SR; Maeland JA
    J Med Microbiol; 2003 May; 52(Pt 5):379-383. PubMed ID: 12721312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ibc proteins.
    Bevanger L
    Antibiot Chemother (1971); 1985; 35():101-13. PubMed ID: 3901887
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infants.
    Gotoff SP; Papierniak CK; Klegerman ME; Boyer KM
    J Pediatr; 1984 Oct; 105(4):628-30. PubMed ID: 6207281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.